Global obesity is on the rise, and endocrinologists are at the forefront of diagnosing its underlying causes and prescribing treatment plans. The Society works to reduce prevalence of obesity through various means, including development and release of scientific statements and practice guidelines, and advocacy for policies and positions that ensure access to affordable treatments. As new obesity medications come to market, the Society will play an important role in educating providers and patients on their optimal usage.
Obesity is a complex disease that is associated with various comorbidities, increased mortality, and reduced quality of life. Abdominal obesity is one of the components of metabolic syndrome (MetS), a cluster of risk factors that increases an individual’s risk for chronic conditions such as cardiovascular disease and diabetes. Our recent Obesity Report details the epidemiology of obesity and MetS by age, race, and geographic location and includes data on the direct costs associated with obesity and MetS. Learn more about the science of obesity in our 2021 Thematic Issue on Obesity.
We are proud to champion Obesity Care Week #OCW2024 to raise awareness about obesity. Obesity Care Week was founded in 2015 and has a global vision for a society that understands, respects and accepts the complexities of obesity and values science and clinically-based care.
